Manipal Health Enterprises Limited (NSE:MANIPALHOS)

Market Cap	981.40B
Revenue (ttm)	111.89B +131.2%
Net Income	8.74B +106.9%
EPS	7.46 +98.5%
Shares Out	1.32B
PE Ratio	99.96
Forward PE	56.84
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,314,012
Open	756.00
Previous Close	747.15
Day's Range	743.10 - 769.75
52-Week Range	625.45 - 815.00
Beta	n/a
Analysts	Buy
Price Target	842.50 (+12.85%)
Est. Earnings	Nov 20, 2026

About NSE:MANIPALHOS

Manipal Health Enterprises Limited operates hospitals in India. The company offers services, such as multi-specialty tertiary and quaternary care through its network of hospitals. Its services include accident and emergency care, cancer care, cardiology, organ transplants, obstetrics and gynaecology, neurology, nephrology, orthopaedics, proctology, rheumatology, and urology. The company also offers medical services, including robotic spine surgery, bariatric surgery, head and neck surgery, liver transplantation, dialysis, laparoscopic surgery, ...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1991
• Employees: 24,240
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MANIPALHOS

Financial Performance

In fiscal year 2026, NSE:MANIPALHOS's revenue was 103.36 billion, an increase of 25.40% compared to the previous year's 82.42 billion. Earnings were 8.92 billion, a decrease of -16.24%.

Analyst Summary

According to 8 analysts, the average rating for MANIPALHOS stock is "Buy." The 12-month stock price target is ₹842.50, which is an increase of 12.85% from the latest price.

Price Target

₹842.50

(12.85% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 22, 2026

Data Sources Report a data error